This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Dainippon Pharmaceutical Company, Limited, Laboratoire Roger Bellon. Active years: 1984.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1984
Title: Yu Imasato: Innovator in Pharmaceutical Compounds
Introduction
Yu Imasato is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on naphthyridine derivatives. His research has led to advancements that enhance the stability and efficacy of pharmaceutical compounds.
Latest Patents
Yu Imasato holds a patent for the sesquihydrate of a naphthyridine derivative, specifically the novel compound 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid sesquihydrate (ATT-2266.sesquihydrate). This compound can be synthesized by heating the corresponding acid in the presence of water at temperatures above 60 degrees Celsius. The sesquihydrate form exhibits greater stability compared to its anhydrate and trihydrate counterparts, making it particularly advantageous for pharmaceutical applications due to its improved dissolution rate and absorption through the intestines.
Career Highlights
Throughout his career, Yu Imasato has worked with prominent organizations, including Dainippon Pharmaceutical Company, Limited and Laboratoire Roger Bellon. His experience in these companies has allowed him to refine his expertise in pharmaceutical development and innovation.
Collaborations
Yu has collaborated with esteemed colleagues such as Hitoshi Ichihashi and Terukazu Tanaka. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Yu Imasato's contributions to the field of pharmaceuticals, particularly through his innovative patent on naphthyridine derivatives, highlight his role as a significant inventor. His work continues to influence the development of effective pharmaceutical compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile